HHC
CBST

Hutchin Hill Capital’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Hutchin Hill Capital’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,200
Closed -$345K – 795
2014
Q3 		$345K Sell
5,200
-4,800
-48% -$315K 0.01% 508
2014
Q2 		$698K Sell
10,000
-9,500
-49% -$646K 0.03% 399
2014
Q1 		$1.43M Hold
19,500
– – 0.07% 292
2013
Q4 		$1.34M Sell
19,500
-6,800
-26% -$440K 0.09% 229
2013
Q3 		$1.67M Sell
26,300
-8,700
-25% -$526K 0.15% 115
2013
Q2 		$1.69M Buy
+35,000
New +$1.72M 0.17% 89

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hutchin Hill Capital's CBST Position: Q4 2014 in Review

Hutchin Hill Capital sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 5,200 shares — an estimated $345K sold.

Hutchin Hill Capital first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $1.69M in Q2 2013. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Hutchin Hill Capital reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Hutchin Hill Capital sold 5,200 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $345K.
  • Hutchin Hill Capital first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Hutchin Hill Capital's CUBIST PHARMACEUTICALS INC position peaked at $1.69M in Q2 2013.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Hutchin Hill Capital's 13F filing for Q4 2014, filed 17 Feb 2015.